NKT-like cell frequency positively correlates with HBV DNA in patients with CHB.
NKT-like cell frequency decreases in patients who respond to telbivudine.
NKT-like cell frequency positively correlates with serum IL-17 in CHB patients.
NKT-like cells may be a immunologic marker of the efficacy of anti-HBV therapy.
NKT-like cells may be an important source of IL-17 in patients with CHB.